Financhill
Back

SPDR® SSgA Multi-Asset Real Return ETF Vs. Avidity Biosciences Industry Stock Comparison

Sell
27

RLY
SPDR® SSgA Multi-Asset Real Return ETF

Last Price:
28.45
Seasonality Move:
0.11%
Sell
28

RNA
Avidity Biosciences

Last Price:
41.33
Seasonality Move:
39.98%
Sell
27
SPDR® SSgA Multi-Asset Real Return ETF (RLY) is a Sell

Is SPDR® SSgA Multi-Asset Real Return ETF a Buy, Sell or Hold?

  • The current SPDR® SSgA Multi-Asset Real Return ETF [RLY] share price is $28.15. The Score for RLY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • RLY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLY Stock Price Chart

What is SPDR® SSgA Multi-Asset Real Return ETF's stock price today?

  • The SPDR® SSgA Multi-Asset Real Return ETF share price today is $28.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.

RLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 40.88 Sell
Chaikin Money Flow: 16342 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.41 Sell
20-day SMA: 28.48 Sell
50-day SMA: 28.52 Sell
200-day SMA: 27.93 Buy
8-day EMA: 28.3 Sell
20-day EMA: 28.45 Sell
50-day EMA: 28.44 Sell
200-day EMA: 28.01 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

SPDR® SSgA Multi-Asset Real Return ETF Earnings Growth & RLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.26 per share.

SPDR® SSgA Multi-Asset Real Return ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):